Summit Therapeutics Inc. (SMMT)
BMV
Closed
Aug 24, 2026
Day's Range
290.1252 wk Range
281.00Overview - SMMT - Summit Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
3.91T
P/E (Trailing)
‪-201.47‬
PEG Ratio
‪3.18‬
Price / Book
‪21.41‬
EV / EBITDA
‪-263.84‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-101.61%‬
Return on Equity
‪-192.50%‬
Ownership
Shares Outstanding
793.12M
Float
152.28M
Held by Insiders
‪80.89%‬
Held by Institutions
‪17.36%‬
Price stats
Beta
‪-1.24‬
50-Day Avg
‪290.12‬
200-Day Avg
‪332.02‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - SMMT - Summit Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- SMMTBMVSummit Therapeutics Inc.231.44BMarket Cap-46.60%52-week change-201.47P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.44P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.215.02BMarket Cap+3.02%52-week change176.04P/E (Trailing)‪2.14%‬Profit Margin
- ACADBMVAcadia Pharmaceuticals Inc.77.69BMarket Cap-12.18%52-week change13.49P/E (Trailing)‪33.41%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - SMMT - Summit Therapeutics Inc.
About
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicinal therapies designed to be patient, physician, caregiver, and societally friendly. Its lead candidate, ivonescimab, is a first-in-class bispecific antibody that simultaneously…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
